A/Prof Marina Pajic
Immunology and anti-invasive treatments for pancreatic cancer: a new therapeutic partnership
Grant
Immunology and anti-invasive treatments for pancreatic cancer: a new therapeutic partnership
Award
2015 "Woolies on Wheels" Innovation Grant
Institution
The Garvan Institute of Medical Research, The Kinghorn Cancer Centre, Cancer Division
Principal Investigator
Dr Marina Pajic, Group Leader, Personalised Cancer Therapeutics (since 2013) - Garvan Institute of Medical Research, The Kinghorn Cancer Centre
Time required to complete project
1 year
Project Summary
Dr. Pajic and her team identified 13 major subtypes of pancreatic cancer based on differences in the DNA of tumours. They aim to examine which of these tumour subtypes are most likely to respond to a novel combination therapy using targeted and individually promising agents, Ruxolitinib and Dasatinib. They believe their research is at the forefront of personalised medicine and ensures patients get the best treatment suited to their exact cancer.
Research Reports
Click to download progress reporting on the outcomes of this research.
‘Woolies on Wheels’ Innovation Grants
The Avner Pancreatic Cancer Foundation's four "Woolies on Wheels" have been made possible by the efforts of the Woolworths business leaders who cycled the 2014 ‘Woolies on Wheels’ charity cycle to raise funds in support of Avner Pancreatic Cancer Foundation. The grants will support $100,000 in seed funding for innovative Pancreatic Cancer projects with a desire to increase interest and investment in pancreatic cancer research.
The objectives of the ‘Woolies on Wheels’ Innovation grants are to:
- Support established scientists and/or early career researchers to develop preliminary data necessary to support pursuit of additional funding in subsequent years.
- Encourage and retain talented skilled individuals in the field of pancreatic cancer.
Emphasis will be given to support novel approaches examples of which would include immunotherapy.